2020-12-07,Lyra Therapeutics Announces Positive Topline Results for LANTERN Phase 2 Randomized Controlled Study of LYR-210 for the Treatment of Chronic Rhinosinusitis With and Without Nasal Polyps
2020-12-02,"Is Lyra Therapeutics, Inc. (LYRA) A Good Stock To Buy?"
2020-11-12,Lyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual London Healthcare Conference
2020-11-10,Lyra Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-02,"What Is The Ownership Structure Like For Lyra Therapeutics, Inc. (NASDAQ:LYRA)?"
2020-10-28,Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors
2020-09-10,Lyra Therapeutics Presents Clinical Data Demonstrating LYR-210s Local Anti Inflammatory Effects for the Treatment of Chronic Rhinosinusitis
2020-09-03,Lyra Therapeutics to Present Data Supporting LYR-210 for the Treatment of Chronic Rhinosinusitis
2020-08-05,Lyra Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-04,Lyra Therapeutics to Present at the BTIG Virtual Biotechnology Conference
2020-08-04,Lyra Therapeutics Announces Pamela Nelson as Senior Vice President of Regulatory Affairs
2020-08-03,We're Hopeful That Lyra Therapeutics (NASDAQ:LYRA) Will Use Its Cash Wisely
2020-07-30,Lyra Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference
2020-07-24,Lyra Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update
2020-07-07,"Lyra Therapeutics Announces Robert Richard, Ph.D., as Senior Vice President of Research and Development"
2020-06-25,Lyra Therapeutics Set to Join the Russell 2000® Index and Russell 3000® Index
2020-06-05,"Lyra Therapeutics, e.l.f. Beauty, and Avid Tech See Activist Action"
2020-05-28,Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-28,Lyra Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference
2020-05-08,Lyra Therapeutics to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference
2020-05-05,Lyra Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of Underwriters Option to Purchase Additional Shares
